Active ingredient
Hetastarch
3 finished FDA listings contain Hetastarch as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- HETASTARCH
- Dosage forms
- Injection, Solution
- Routes
- Intravenous
- Manufacturers / labelers
- 2
- Strengths listed
- 6 g/100ml
- Brand names in FDA listings
- Hetastarch In Sodium Chloride, Hextend
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 5531
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
No matching Drugs@FDA applications.
Official labeling on DailyMed
- HEXTEND (HETASTARCH) INJECTION, SOLUTION [HOSPIRA, INC.] · version 25 · 2026-05-21
- HETASTARCH IN SODIUM CHLORIDE (HETASTARCH) INJECTION, SOLUTION [HOSPIRA, INC.] · version 26 · 2026-05-01
- 6% HETASTARCH IN 0.9% SODIUM CHLORIDE INJECTION, SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST] · version 6 · 2024-01-31
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.